Study to Assess the Prophylactic Efficacy and Safety of Sebaloxavir Marboxil Tablets/Oral Suspension for Influenza Prevention in Household Contacts Aged ≥2 Years.

NCT07730346 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

858

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza Prevention

Interventions

DRUG: Sebaloxavir marboxil
DRUG: Placebo

Sponsor

Nanjing Zenshine Pharmaceuticals